Association between UCHL1 RNA expression and survival in the CPTAC cohort (median split, log-rank test)
The benefits are well documented across many applications: faster tissue healing (3050% faster than natural healing), strong inflammation control without the side effects of traditional drugs, enhanced new blood vessel formation, less scar tissue (4050% less fibrosis), better functional recovery, healing across all tissue types (muscle, tendon, ligament, bone, organs), gut healing and protection, possible neuroprotective effects, cardiac protective properties, and an excellent safety profile with minimal side effects
1d) with activity against recombinant TGR improving from the mM range for the fragments alone to the single digit M range
Medical management update: Peutz Jeghers syndrome